Sign In
Buy OPY
$106.64
-4.06 (-3.67%)
At Close: Jul 31, 2026
Craig Schneider Joins Oppenheimer As Regional Director of Michigan
09:00am, Wednesday, 04'th Dec 2024
Wealth Management Veteran Brings Over 25 Years of Industry Experience Appointment Builds on Firm's Momentum Created by Recent Appointments to Strengthen its Presence in Virginia, Georgia, Tennessee an
WillScot to Participate in Oppenheimer Midwest Virtual Summit
08:00am, Wednesday, 04'th Dec 2024
PHOENIX, Dec. 04, 2024 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary flexible space solutions, today announced
Satellos to Participate in Oppenheimer Movers in Rare Disease Summit
07:00am, Tuesday, 03'rd Dec 2024
TORONTO--(BUSINESS WIRE)--Satellos Bioscience Inc. (TSX:MSCL, OTCQB:MSCLF) (“Satellos”), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of m
Chemomab to Participate in Oppenheimer's Movers in Rare Disease Summit
07:00am, Tuesday, 03'rd Dec 2024
—Movers in Rare Disease Summit Will Include Elevator Pitches from Rare Disease Companies with “Key, Near-Term, Potentially Stock-Moving Catalysts”— TEL AVIV, Israel, Dec. 03, 2024 (GLOBE NEWSW
Pontera and Oppenheimer partner to empower holistic wealth management that incorporates clients' 401(k)s
09:03am, Thursday, 14'th Nov 2024
Top 10 U.S. broker-dealer will leverage Pontera's secure platform to manage workplace retirement accounts and help clients optimize their returns NEW YORK , Nov. 14, 2024 /PRNewswire/ -- Pontera™,
Oppenheimer Concludes 20th Annual Professionals Alliance Group (PAG) Conference
12:30pm, Wednesday, 13'th Nov 2024
Event Gathered CPAs and Other Trusted Industry Professionals with Select Group of Oppenheimer Advisors, Investment Managers and Senior Leadership to Collaborate on Strategies to Deliver Enhanced Clien
Oppenheimer's Brian Nagel on Home Depot Q3 results: Largely a weather-driven sales upside
08:57am, Tuesday, 12'th Nov 2024
Brian Nagel, Oppenheimer senior analyst, joins 'Squawk Box' to break down Home Depot's Q3 earnings results.
Vor Bio price target lowered to $8 from $10 at Oppenheimer
02:27pm, Friday, 08'th Nov 2024
Oppenheimer analyst Matthew Biegler lowered the firm's price target on Vor Bio to $8 from $10 and keeps an Outperform rating on the shares following the Q3 report. The firm cites updated spending esti
Call of the Day: Oppenheimer raises bank targets
02:12pm, Tuesday, 05'th Nov 2024
The Investment Committee debate the big bank names.
Oppenheimer Holdings: Mid-Market Prevailing In Capital Markets, Solid All Around
09:10am, Saturday, 26'th Oct 2024
Oppenheimer's earnings report show strength in mid-market capital markets franchise as well as solid growth in the rest of its AUM and commission based businesses. Risk taking in public markets has dr
Oppenheimer Holdings Inc. Reports Third Quarter 2024 Earnings
08:00am, Friday, 25'th Oct 2024
NEW YORK , Oct. 25, 2024 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $24.5 million or $2.38 basic earnings per share for the third quart
Oppenheimer Hires Christian Baetz As Managing Director, Consumer Investment Banking
06:00am, Tuesday, 15'th Oct 2024
NEW YORK , Oct. 15, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today th
Oppenheimer downgrades Microsoft: OpenAI losses are not properly priced in
12:30pm, Tuesday, 08'th Oct 2024
Timothy Horan, Oppenheimer managing director and senior analyst, joins 'Money Movers' to discuss the firm's downgrade of Microsoft's stock.
SEATTLE, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced tre
Oppenheimer Names Todd Wiggins Regional Director of Dallas-Fort Worth Region
06:00am, Tuesday, 01'st Oct 2024
Industry Veteran to Bring His Experience Leading, Attracting, and Retaining Advisors to His New Location NEW YORK , Oct. 1, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") – a leading we
